Emanuela Messina

797 total citations
37 papers, 224 citations indexed

About

Emanuela Messina is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Emanuela Messina has authored 37 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 19 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Emanuela Messina's work include Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Emanuela Messina is often cited by papers focused on Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Emanuela Messina collaborates with scholars based in Italy, United States and Canada. Emanuela Messina's co-authors include Caterina Uberti‐Foppa, Hamid Hasson, Giulia Morsica, Sabrina Bagaglio, Laura Galli, Adriano Lazzarin, Antonella Castagna, Marco Merli, Stefania Salpietro and Andrea Andolina and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and The Lancet Infectious Diseases.

In The Last Decade

Emanuela Messina

34 papers receiving 218 citations

Peers

Emanuela Messina
Anne-Marie Taburet France
Ray Chung United States
Lana Kosi Austria
Kamila Wójcik Poland
Hayley Farmer United States
Abraham O. Malu Nigeria
F Maggiolo Italy
G Schmutz Germany
Ricky Hsu United States
Maria Caceres United States
Anne-Marie Taburet France
Emanuela Messina
Citations per year, relative to Emanuela Messina Emanuela Messina (= 1×) peers Anne-Marie Taburet

Countries citing papers authored by Emanuela Messina

Since Specialization
Citations

This map shows the geographic impact of Emanuela Messina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Messina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Messina more than expected).

Fields of papers citing papers by Emanuela Messina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Messina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Messina. The network helps show where Emanuela Messina may publish in the future.

Co-authorship network of co-authors of Emanuela Messina

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Messina. A scholar is included among the top collaborators of Emanuela Messina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Messina. Emanuela Messina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messina, Emanuela, Angelo Roberto Raccagni, Nicola Clementi, et al.. (2023). A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination. The Lancet Infectious Diseases. 24(1). e11–e12. 1 indexed citations
2.
Damanti, Sarah, Marta Cilla, Giordano Vitali, et al.. (2023). Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective. Nutrients. 15(22). 4727–4727. 2 indexed citations
3.
Raccagni, Angelo Roberto, Laura Galli, Caterina Candela, et al.. (2023). High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy. AIDS and Behavior. 28(3). 907–911. 3 indexed citations
4.
Morsica, Giulia, Laura Galli, Emanuela Messina, et al.. (2022). Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients. Journal of Oncology. 2022. 1–10. 5 indexed citations
5.
Walmsley, Sharon, Terry Lee, Joel Singer, et al.. (2022). BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period. AIDS Research and Human Retroviruses. 39(4). 204–210. 6 indexed citations
6.
Morsica, Giulia, Laura Galli, Emanuela Messina, et al.. (2022). Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV. PLoS ONE. 17(2). e0262917–e0262917. 2 indexed citations
7.
Bruzzesi, Elena, Laura Galli, Simona Bossolasco, et al.. (2022). Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(2). 226–231. 14 indexed citations
8.
Messina, Emanuela, Anna Danise, Giulio Ferrari, et al.. (2021). Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series. Infectious Diseases and Therapy. 10(4). 2791–2804. 15 indexed citations
9.
Bagaglio, Sabrina, Caterina Uberti‐Foppa, Caterina Sagnelli, et al.. (2020). HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy. Infection. 48(4). 553–558. 7 indexed citations
10.
Sagnelli, Caterina, Caterina Uberti‐Foppa, Sabrina Bagaglio, et al.. (2020). Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy. Epidemiology and Infection. 148. e19–e19. 11 indexed citations
11.
12.
Sagnelli, Caterina, Caterina Uberti‐Foppa, Hamid Hasson, et al.. (2018). In vivoevidence that the cannabinoid receptor 2–63RRvariant is associated with the acquisition and/or expansion ofHIVinfection. HIV Medicine. 19(9). 597–604. 6 indexed citations
13.
Bagaglio, Sabrina, et al.. (2018). Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates. Virology Journal. 15(1). 144–144. 4 indexed citations
14.
Sagnelli, Caterina, Caterina Uberti‐Foppa, Hamid Hasson, et al.. (2017). Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. PLoS ONE. 12(7). e0181890–e0181890. 11 indexed citations
15.
Pinato, David J., Marco Merli, Alessia Dalla Pria, et al.. (2017). Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma. Oncology. 93(6). 395–400. 7 indexed citations
16.
Merli, Marco, Laura Galli, Letizia Marinaro, et al.. (2016). Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis. Journal of Antimicrobial Chemotherapy. 72(3). dkw492–dkw492. 8 indexed citations
17.
Sagnelli, Caterina, Marco Merli, Caterina Uberti‐Foppa, et al.. (2016). TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype. World Journal of Gastroenterology. 22(38). 8509–8509. 10 indexed citations
18.
Merli, Marco, Laura Galli, Antonella Castagna, et al.. (2016). Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.. PubMed. 39(2). 110–3. 11 indexed citations
19.
Bagaglio, Sabrina, Caterina Uberti‐Foppa, Clelia Di Serio, et al.. (2015). Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin. Medicine. 94(43). e1876–e1876. 8 indexed citations
20.
Bagaglio, Sabrina, Caterina Uberti‐Foppa, Emanuela Messina, et al.. (2015). Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients. Clinical Microbiology and Infection. 22(4). 386.e1–386.e3. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne-Marie Taburet Breakdown of academic impact, for papers by Ray Chung Breakdown of academic impact, for papers by Lana Kosi Breakdown of academic impact, for papers by Kamila Wójcik Breakdown of academic impact, for papers by Hayley Farmer Breakdown of academic impact, for papers by Abraham O. Malu Breakdown of academic impact, for papers by F Maggiolo Breakdown of academic impact, for papers by G Schmutz Breakdown of academic impact, for papers by Ricky Hsu Breakdown of academic impact, for papers by Maria Caceres
Rankless by CCL
2026